Artificial Intelligence in Head and Neck Surgery:  Revolutionising Treatment with Some Growing Pains

Dr Rohit Narendra Rathod *

*Correspondence to: Dr Rohit Narendra Rathod, Consultant in the Department of Head & Neck Oncology Shakus Medicity – SMC Meshana  F.I.B.O.M.S, M.D.S, F.F.A.S, F.H.N.O, F.H.N.S, P.D.C.R, AOCMF-G.O.C.D, G.F.P.M, F.P.F.A.F.I.C.S.

Copyright.

© 2025 Dr Rohit Narendra Rathod, This is an open access article distributed under the Creative Commons Attribution   License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 05 November 2025

Published: 01 December 2025

DOI: https://doi.org/10.5281/zenodo.17798184 

Introduction

Fake Insights AI can robotise forms that combine complex factors with shifting levels of weighting into an expository pathway, the outcome of which gives direction for clinical decision-making. AI has points of interest such as screening of high-risk populaces, discovery and classification of cancerous injuries, elucidation of pictures as typical verbal mucosa/precancerous/cancerous injuries, ease of utilize in multigenre ponder, computerized learning without human intervention, capacity to always prepare on assist information, direct clinician in decision-making, potential for combination of history, geological information, hazard components, imaging highlights, and radio mics information to produce chance evaluations, expectation of threatening change, discovery of exact biomarkers, lymph hub metastasis forecast, and bolster clinician in treatment planning- g.AI and verbal cancer inquire about utilize an assortment of datasets, counting clinical pictures, photographic pictures, autofluorescence pictures, optical coherence tomography, Raman spectroscopy, spectroscopy test, confocal laser endomicroscopy pictures, multidimensional hyperspectral pictures, quality expression information, radiographic pictures, spit metabolites, histopathologic pictures, and P 53 immunostained tissue segments [1–4]. Following the starting wave of energy encompassing AI and radiology, desires have presently tempered. The current centre focuses on how AI can advance understanding of care through mechanisation and automation, as well as on increasing or perhaps replacing the physician's current roles. The quality, quantity, and inclinations of the information utilised to prepare and approve the models will not address all healthcare issues, but AI will be an effective tool for advancing the delivery of quality healthcare [5]. There are various issues with the utilisation of AI in healthcare settings that we must be mindful of, and there ought to be interest in identifying these issues and potential solutions. A few of the issues/ issues with AI are recorded below.

Problems with AI

Protection and secrecy of understanding information stay major obstacles in the clinical application of AI in oncology. There are questions concerning methodological perspectives, unexpected results, and misfortune of privacy and independence. Creators have raised concerns almost security, inclination, and educated assent. Check Henderson Arnold communicates comparative concerns [6–9]. Bias is a major obstruction to the far reaching appropriation of AI, and Bar- lished considers, have a tall chance of inclination and need of straightforwardness [5,10]. Reproducibility and generalizability of AI models [5]. The danger of cyber-security, precision, and need of compassion and confront- to-face relationship [5,11]. Training frameworks to classify uncommon discoveries require huge information and a higher human time with additional capital taken a toll [5,12]. There are challenges related to organization and preprocessing of large-scale information required to get clinically solid calculations [10]. In the directed preparing of machine learning calculations, supreme ground truth is troublesome to accomplish. Human information naming is a common source of ground truth. This naming prepare may be subjective or sub- ject to master difference. Clinicians ought to give understanding and collaborate with information science engineers on particular injuries qualities in connection to the determination conventions that are taken after [5,13]. Big information is a computational convention in which information or maybe than hy- pothesis testing drives choices. When creating prove, these strategies depend on crude perceptions and do not take setting into account. The conveyance of preparing information influences AI-based approaches, coming about in destitute comes about for testing information exterior of the preparing information. Since the information in each clinical situation is special, these approaches are not strong sufficient to be utilized in practical applications. Another point of dispute is the sum of information required to get precise, dependable data [9, 14–17]. AI improvement and testing forms and approaches do not follow to the chronicled frequentist speculation system, posturing a boundary to progressed clinical application and outside approval. The utilize of computational strategies to explore models with potential clinical pertinence raises moral concerns in speculation era inquire about. Profound learning-based approaches are respected as “black boxes” since they need interpretability, though image-based machine-learning ap- proaches require steady and large-scale curated and institutionalized picture information procurement [17–20].

AI models are built with retrospective and heterogeneous data, which Fake Insights AI can robotize forms that combine com- plex factors with shifting levels of weighting into an expository pathway, the comes about of which give direction for clinical choice making. AI has points of interest such as screening of high-risk populaces, discovery and classification of cancerous injuries, elucidation of pictures as typical verbal mucosa/precancerous/cancerous injuries, ease of utilize in multicentre ponder, computerized learning without human intervention, capacity to always prepare on assist information, direct clinician in decision-making, po- tential for combination of history, geological information, hazard components, imag- ing highlights, and radiomics information to produce chance evaluations, expectation of threatening change, discovery of exact biomarkers, lymph hub metastasis forecast, and bolster clinician in treatment plannin- g.AI and verbal cancer inquire about utilize a assortment of datasets, counting clinical pictures, photographic pictures, autofluorescence pictures, optical coher- ence tomography, Raman spectroscopy, spectroscopy test, confocal laser endomicroscopy pictures, multidimensional hyperspectral pictures, quality expression information, radiographic pictures, spit metabolites, histo- pathologic pictures, and P 53 immunostained tissue segments [1–4]. Following the starting wave of energy encompassing AI and radi- ology, desires have presently tempered.

The current center is on how AI can move forward understanding care through mechanization and proficiency, as well as increasing or maybe than supplanting the physician's current parts. The quality, sum, and inclinations of the information utilized to prepare and approve the models will not illuminate all wellbeing segment issues, but AI will be a effective device for making strides the conveyance of quality wellbeing care [5]. There are various issues with the utilize of AI in healthcare settings that we must be mindful of, and there ought to be intrigue disk- sions almost these issues and potential arrangements. A few of the issues/ issues with AI are recorded below.

References

1. Hegde S, Ajila V, Zhu W, Zeng C. Artificial intelligence in early diagnosis and prevention of oral cancer. Asia Pac J Oncol Nurs 2022 Aug 24;9(12):100133. https://doi.org/10.1016/j.apjon.2022.100133. PMID: 36389623; PMCID: PMC9664349.
2. Khanagar SB, Naik S, Al Kheraif AA, Vishwanathaiah S, Maganur PC, Alhazmi Y, Mushtaq S, Sarode SC, Sarode GS, Zanza A, Testarelli L, Patil S. Application and performance of artificial intelligence technology in oral cancer diagnosis and pre- diction of prognosis: a systematic review. Diagnostics 2021 May 31;11(6):1004. https://doi.org/10.3390/diagnostics11061004. PMID: 34072804; PMCID: PMC8227647.
3. Mahmood H, Shaban M, Rajpoot N, Khurram SA. Artificial Intelligence-based methods in head and neck cancer diagnosis: an overview. Br J Cancer 2021 Jun; 124(12):1934–40. https://doi.org/10.1038/s41416-021-01386-x. Epub 2021 Apr 19. PMID: 33875821; PMCID: PMC8184820.
4.  Mahmood H, Shaban M, Indave BI, Santos-Silva AR, Rajpoot N, Khurram SA. Use of artificial intelligence in diagnosis of head and neck precancerous and cancerous lesions: a systematic review. Oral Oncol 2020 Nov;110:104885. https://doi.org/ 10.1016/j.oraloncology.2020.104885. Epub 2020 Jul 13. PMID: 32674040.
5.  Werth K, Ledbetter L. Artificial intelligence in head and neck imaging: a glimpse into the future. Neuroimaging Clin 2020 Aug;30(3):359–68. https://doi.org/ 10.1016/j.nic.2020.04.004. Epub 2020 Jun 10. PMID: 32600636.
6.   Al-Rawi N, Sultan A, Rajai B, Shuaeeb H, Alnajjar M, Alketbi M, Mohammad Y, Shetty SR, Mashrah MA. The effectiveness of artificial intelligence in detection of oral cancer. Int Dent J 2022 Aug;72(4):436–47. https://doi.org/10.1016/ j.identj.2022.03.001. Epub 2022 May 14. PMID: 35581039; PMCID: PMC9381387.
7. Da Silva M, Horsley T, Singh D, Da Silva E, Ly V, Thomas B, Daniel RC, Chagal- Feferkorn KA, Iantomasi S, White K, Kent A, Flood CM. Legal concerns in health- related artificial intelligence: a scoping review protocol. Syst Rev 2022 Jun 17; 11(1):123. https://doi.org/10.1186/s13643-022-01939-y. PMID: 35715812; PMCID: PMC9204372.
8.  Blasimme A, Vayena E. The ethics of AI in biomedical research, medicine and public health. In: Dubber MD, et al., editors. The oxford handbook of ethics of AI oxford. Oxford UP; 2020.
9. Resteghini C, Trama A, Borgonovi E, Hosni H, Corrao G, Orlandi E, Calareso G, De Cecco L, Piazza C, Mainardi L, Licitra L. Big data in head and neck cancer. Curr Treat Options Oncol 2018 Oct 25;19(12):62. https://doi.org/10.1007/s11864-018- 0585-2. PMID: 30361937.
10.  Cellina M, Ce M, Khenkina N, Sinichich P, Cervelli M, Poggi V, Boemi S, Ierardi AM, Carrafiello G. Artificial intellgence in the era of precision oncological imaging. Technol Cancer Res Treat 2022 Jan-Dec;21:15330338221141793. https://doi.org/ 10.1177/15330338221141793. Erratum in: Technol Cancer Res Treat. 2023 Jan- Dec;22:15330338231153330. PMID: 36426565; PMCID: PMC9703524.
11.  Zhang Z, Citardi D, Wang D, Genc Y, Shan J, Fan X. Patients' perceptions of using artificial intelligence (AI)-based technology to comprehend radiology imaging data. Health Inf J 2021 Apr-Jun;27(2):14604582211011215. https://doi.org/10.1177/ 14604582211011215. PMID: 33913359.
12.   Choy G, Khalilzadeh O, Michalski M, Do S, Samir AE, Pianykh OS, Geis JR, Pandharipande PV, Brink JA, Dreyer KJ. Current applications and future impact of machine learning in radiology. Radiology 2018 Aug;288(2):318–28. https:// doi.org/10.1148/radiol.2018171820. Epub 2018 Jun 26. PMID: 29944078; PMCID: PMC6542626.
13.   Trivizakis E, Papadakis GZ, Souglakos I, Papanikolaou N, Koumakis L, Spandidos DA, Tsatsakis A, Karantanas AH, Marias K. Artificial intelligence radio- genomics for advancing precision and effectiveness in oncologic care (Review). Int J Oncol 2020 Jul;57(1):43–53. https://doi.org/10.3892/ijo.2020.5063. Epub 2020 May 11. PMID: 32467997; PMCID: PMC7252460.
14. Shah ND, Steyerberg EW, Kent DM. Big data and predictive analytics: recalibrating expectations. JAMA 2018 Jul 3;320(1):27–8. https://doi.org/10.1001/ jama.2018.5602. PMID: 29813156.
15. Hersh WR, Weiner MG, Embi PJ, Logan JR, Payne PR, Bernstam EV, Lehmann HP, Hripcsak G, Hartzog TH, Cimino JJ, Saltz JH. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care 2013 Aug;51(8 Suppl 3):S30–7. https://doi.org/10.1097/MLR.0b013e31829b1dbd. PMID: 23774517; PMCID: PMC3748381.
16. Sim I. Two ways of knowing: big data and evidence-based medicine. Ann Intern Med 2016 Apr 19;164(8):562–3. https://doi.org/10.7326/M15-2970. Epub 2016 Jan 26. PMID: 26809201.
17. Zhao W, Shen L, Islam MT, Qin W, Zhang Z, Liang X, Zhang G, Xu S, Li X. Artificial intelligence in image-guided radiotherapy: a review of treatment target localiza- tion. Quant Imag Med Surg 2021 Dec;11(12):4881–94. https://doi.org/10.21037/ qims-21-199. PMID: 34888196; PMCID: PMC8611462.
18. Istasy P, Lee WS, Iansavichene A, Upshur R, Gyawali B, Burkell J, Sadikovic B, Lazo- Langner A, Chin-Yee B. The impact of artificial intelligence on health equity in oncology: scoping review. J Med Internet Res 2022 Nov 1;24(11):e39748. https:// doi.org/10.2196/39748. PMID: 36005841; PMCID: PMC9667381.
19. McCradden MD, Anderson JA, A Stephenson E, Drysdale E, Erdman L, Goldenberg A, Zlotnik Shaul R. A research ethics framework for the clinical translation of healthcare machine learning. Am J Bioeth 2022 May;22(5):8–22. 20]  van Dijk LV, Fuller CD. Artificial intelligence and radiomics in head and neck cancer care: opportunities, mechanics, and challenges. Am Soc Clin Oncol Educ Book 2021 Mar;41:1–11. https://doi.org/10.1200/EDBK_320951. PMID: 33929877; PMCID: PMC8218312.
20. Arnold MH. Teasing out artificial intelligence in medicine: an ethical critique of artificial intelligence and machine learning in medicine. J bioeth Inq 2021 Mar; 18(1):121–39. https://doi.org/10.1007/s11673-020-10080-1. Epub 2021 Jan 7. PMID: 33415596; PMCID: PMC7790358.
21. Prior FW, Brunsden B, Hildebolt C, Nolan TS, Pringle M, Vaishnavi SN, Larson- Prior LJ. Facial recognition from volume-rendered magnetic resonance imaging data. IEEE Trans Inf Technol Biomed 2009 Jan;13(1):5–9. https://doi.org/10.1109/ TITB.2008.2003335. PMID: 19129018.
22. Alabi RO, Tero V, Mohammed E. Machine learning for prognosis of oral cancer: what are the ethical challenges? CEURWorkshop Proceedings 2020;2373:1–22.
23. Gerke S, et al. Ethical and legal challenges of artificially intelligencedriven healthcare. In: Bohr B, Memarzadeh K, editors. Artificial intelligence in healthcare. Cambridge: Academic Press; 2020.
24. DeJohn CR, Grant SR, Seshadri M. Application of machine learning methods to improve the performance of ultrasound in head and neck oncology: a literature review. Cancers 2022 Jan 28;14(3):665. https://doi.org/10.3390/can- cers14030665. PMID: 35158932; PMCID: PMC8833587.
25. Licitra L, Trama A, Hosni H. Benefits and risks of machine learning decision support systems. JAMA 2017 Dec 19;318(23):2354. https://doi.org/10.1001/ jama.2017.16627. PMID: 29260219.
26. Berner ES, Ozaydin B. Benefits and risks of machine learning decision support systems. JAMA 2017 Dec 19;318(23):2353–4. https://doi.org/10.1001/ jama.2017.16619. PMID: 29260217.